31
August
2018
|
23:32
Asia/Singapore
NUS researchers use AI to successfully treat metastatic cancer patient
A translational research team led by Prof Dean Ho, Director of the Singapore Institute for Neurotechnology at NUS, has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform to successfully treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalised medicine.
- TODAY, 31 August 2018
- Capital 95.8FM, 31 August 2018
- Channel 8 News Online, 31 August 2018
- Lianhe Zaobao, 1 September 2018, p4